retatrutide weight loss efficacy and Safety of GLP‐1 Receptor Agonists, Dual Agonists, and for in Adults With Overweight or Obesity: A Bayesian NMA - Sinha - 2025 - Obesity Retatrutide for weight loss: Study

Murakami et al., 2023a, b

Data availability The source data for all the graphs in main figures in Supplementary Data 1

A recent report demonstrated that Entresto could inhibit ferroptosis to reduce doxorubicin-induced cardiotoxicity

Some jaundice (yellowing of the eyes and skin caused by excess serum bilirubin), increased bleeding, and worsened nausea/vomiting may also develop

Transforming diabetes care: the molecular pathways through which GLP1-RAs impact the kidneys in diabetic kidney disease

The American Society for Metabolic and Bariatric Surgery also reports that weight loss surgery can potentially treat other conditions associated with obesity, including diabetes, heart disease, high blood pressure, joint pain, sleep apnea, and arthritis, and reduce the risk of cancer